Loading...
| A03496 | Pages: NA | Dec 2021 | 4266 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Internal Tissue Sealants Market
Request Now !Internal tissue sealants are medical devices used after a surgery or a traumatic injury to seal or hold external tissue such as skin and internal tissues such as blood vessels. The global internal tissue sealants market is driven by the need to seal the wounds after injuries or surgeries as it may cause enormous blood loss, which will eventually lead to death, and the launch of cost-effective products in developing economies. However, rise in implementation of minimally invasive surgeries, owing to their higher efficiency and low complications as compared to internal tissue sealants, may restraint the market growth. Furthermore, increase in number of cardiovascular surgeries in Asia-Pacific is expected to create lucrative opportunities for key market players.
The global internal tissue sealants market is segmented based on product, end user, and region. Based on product, it is divided into fibrin-based, collagen-based, protein-based, and synthetic sealants. Based on end user, it is categorized into hospitals, ambulatory surgical centers, and specialty clinics. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players, such as Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi S.A., Braun Melsungen AG, C.R. Bard, Inc., CryoLife Inc., and Cohera Medical, Inc., are also provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 INTERNAL TISSUE SEALANTS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. FIBRIN-BASED
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. COLLAGEN-BASED
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. PROTEIN-BASED
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. SYNTHETIC SEALANTS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 INTERNAL TISSUE SEALANTS MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Key market trends
5.3. AMBULATORY SURGICAL CENTERS
5.3.1. Key market trends
5.4. SPECIALTY CLINICS
5.4.1. Key market trends
CHAPTER 6 INTERNAL TISSUE SEALANTS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Internal Tissue Sealants Market by Product
6.2.5. North America Internal Tissue Sealants Market by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast
6.3.4. Europe Internal Tissue Sealants Market by Product
6.3.5. Europe Internal Tissue Sealants Market by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Internal Tissue Sealants Market by Product
6.4.5. Asia-Pacific Internal Tissue Sealants Market by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Internal Tissue Sealants Market by Product
6.5.5. LAMEA Internal Tissue Sealants Market by End User
CHAPTER 7 COMPANY PROFILES
7.1. ETHICON (JOHNSON & JOHNSON)
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. BAXTER INTERNATIONAL INC.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. PFIZER INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. TISSUEMED LTD.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. SANOFI S.A.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. BRAUN MELSUNGEN AG
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. C.R. BARD, INC.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. CRYOLIFE INC.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. COHERA MEDICAL, INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
